Free Trial

Extendicare Q2 2024 Earnings Report

Extendicare logo
C$10.02 -0.10 (-0.99%)
(As of 12/18/2024 05:28 PM ET)

Extendicare EPS Results

Actual EPS
C$0.29
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Extendicare Revenue Results

Actual Revenue
$348.48 million
Expected Revenue
$360.20 million
Beat/Miss
Missed by -$11.72 million
YoY Revenue Growth
N/A

Extendicare Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.

Extendicare Earnings Headlines

Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Where to Invest $5,000 in October
See More Extendicare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Extendicare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Extendicare and other key companies, straight to your email.

About Extendicare

Extendicare (TSE:EXE), through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

View Extendicare Profile

More Earnings Resources from MarketBeat

Upcoming Earnings